These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 30088838)

  • 1. Comparative Effect of rhPTH(1-84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal Osteoporosis.
    Cipriani C; Pepe J; Silva BC; Rubin MR; Cusano NE; McMahon DJ; Nieddu L; Angelozzi M; Biamonte F; Diacinti D; Hans D; Minisola S; Bilezikian JP
    J Bone Miner Res; 2018 Dec; 33(12):2132-2139. PubMed ID: 30088838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism.
    Cipriani C; Abraham A; Silva BC; Cusano NE; Rubin MR; McMahon DJ; Zhang C; Hans D; Silverberg SJ; Bilezikian JP
    Endocrine; 2017 Feb; 55(2):591-598. PubMed ID: 27757772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
    Bilezikian JP; Hattersley G; Fitzpatrick LA; Harris AG; Shevroja E; Banks K; Leder BZ; Zanchetta JR; Hans D
    Osteoporos Int; 2018 Feb; 29(2):323-328. PubMed ID: 29167971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
    McClung MR; Lippuner K; Brandi ML; Zanchetta JR; Bone HG; Chapurlat R; Hans D; Wang A; Zapalowski C; Libanati C
    Osteoporos Int; 2017 Oct; 28(10):2967-2973. PubMed ID: 28748386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.
    Senn C; Günther B; Popp AW; Perrelet R; Hans D; Lippuner K
    Osteoporos Int; 2014 Jul; 25(7):1945-51. PubMed ID: 24760244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal changes in bone mineral density and trabecular bone score following yearly zoledronic acid infusion in postmenopausal osteoporosis-a retrospective-prospective study from southern India.
    Sooragonda B; Cherian KE; Jebasingh FK; Dasgupta R; Asha HS; Kapoor N; Thomas N; Paul TV
    Arch Osteoporos; 2019 Jul; 14(1):79. PubMed ID: 31321603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis.
    Henriksen K; Andersen JR; Riis BJ; Mehta N; Tavakkol R; Alexandersen P; Byrjalsen I; Valter I; Nedergaard BS; Teglbjaerg CS; Stern W; Sturmer A; Mitta S; Nino AJ; Fitzpatrick LA; Christiansen C; Karsdal MA
    Bone; 2013 Mar; 53(1):160-6. PubMed ID: 23234813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone imaging in hypoparathyroidism.
    Silva BC; Rubin MR; Cusano NE; Bilezikian JP
    Osteoporos Int; 2017 Feb; 28(2):463-471. PubMed ID: 27577725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Endogenous Parathyroid Hormone on Bone Geometry and Skeletal Microarchitecture.
    Hong AR; Lee JH; Kim JH; Kim SW; Shin CS
    Calcif Tissue Int; 2019 Apr; 104(4):382-389. PubMed ID: 30659307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TBS in early postmenopausal women with severe vertebral osteoporosis.
    Pouillès JM; Gosset A; Breteau A; Trémollieres FA
    Bone; 2021 Jan; 142():115698. PubMed ID: 33091641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in Trabecular Bone Score (TBS) With Antiresorptive Therapy Does Not Predict Fracture in Women: The Manitoba BMD Cohort.
    Leslie WD; Majumdar SR; Morin SN; Hans D; Lix LM
    J Bone Miner Res; 2017 Mar; 32(3):618-623. PubMed ID: 27933656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lumbar spine age-related degenerative disease influences the BMD not the TBS: the Osteolaus cohort.
    Padlina I; Gonzalez-Rodriguez E; Hans D; Metzger M; Stoll D; Aubry-Rozier B; Lamy O
    Osteoporos Int; 2017 Mar; 28(3):909-915. PubMed ID: 27900426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study.
    Boutroy S; Hans D; Sornay-Rendu E; Vilayphiou N; Winzenrieth R; Chapurlat R
    Osteoporos Int; 2013 Jan; 24(1):77-85. PubMed ID: 23070481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the value of trabecular bone score in fracture risk assessment of postmenopausal women.
    Mirzaei A; Jahed SA; Nojomi M; Rajaei A; Zabihiyeganeh M
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):389-393. PubMed ID: 29880171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Teriparatide and Sequential Minodronate on Lumbar Spine Bone Mineral Density and Microarchitecture in Osteoporosis.
    Miyaoka D; Imanishi Y; Ohara M; Hayashi N; Nagata Y; Yamada S; Mori K; Emoto M; Inaba M
    Calcif Tissue Int; 2017 Oct; 101(4):396-403. PubMed ID: 28589205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Long-term Administration of rhPTH(1-84) in Hypoparathyroidism by Bone Histomorphometry.
    Rubin MR; Zhou H; Cusano NE; Majeed R; Omeragic B; Gomez M; Nickolas TL; Dempster DW; Bilezikian JP
    J Bone Miner Res; 2018 Nov; 33(11):1931-1939. PubMed ID: 29972871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.
    Greenspan SL; Bone HG; Ettinger MP; Hanley DA; Lindsay R; Zanchetta JR; Blosch CM; Mathisen AL; Morris SA; Marriott TB;
    Ann Intern Med; 2007 Mar; 146(5):326-39. PubMed ID: 17339618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study.
    Briot K; Paternotte S; Kolta S; Eastell R; Reid DM; Felsenberg D; Glüer CC; Roux C
    Bone; 2013 Nov; 57(1):232-6. PubMed ID: 23948677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vertebral Fracture Assessment in Postmenopausal Women With Postsurgical Hypoparathyroidism.
    Cipriani C; Minisola S; Bilezikian JP; Diacinti D; Colangelo L; Piazzolla V; Angelozzi M; Nieddu L; Pepe J; Diacinti D
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1303-1311. PubMed ID: 33567075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rhPTH (1-34), but not elcatonin, increases bone anabolic efficacy in postmenopausal women with osteoporosis.
    Zhang L; Yang M; Liu D; Guo C; Li L; Yang G
    Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):361-6. PubMed ID: 22639400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.